Aditxt (ADTX) Gross Profit Growth (1y) (2023 - 2026)
Aditxt (ADTX) Gross Profit Growth (1y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Aditxt |
2,485.68 |
-2.16 Mn |
2,868.00 |
909.86% |
| Date | Value |
|---|
| Mar 31, 2026 |
909.86% |
| Dec 31, 2025 |
99.95% |
| Sep 30, 2025 |
100.00% |
| Jun 30, 2025 |
-100.00% |
| Mar 31, 2025 |
-97.95% |
| Dec 31, 2024 |
66.84% |
| Sep 30, 2024 |
-2,722.88% |
| Jun 30, 2024 |
-40.01% |
| Mar 31, 2024 |
-65.39% |
| Dec 31, 2023 |
-1,425.79% |
| Sep 30, 2023 |
-80.36% |
| Jun 30, 2023 |
-11.58% |
| Mar 31, 2023 |
80.59% |
